• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH

ALTERITY THERAPEUTICS LIMITED - Discussion

0.00% ! 1.1¢
Market Cap $100.4M  !
Healthcare Biotechnology
Add to My Watchlist

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Alterity Therapeutics Limited

edit-2 Created with Sketch. New Thread
refresh Created with Sketch. REFRESH
Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Jimbob77 507 157K 10 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 10
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 2 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 2
ASX - By Stock ATH Re: 553,461 shorted shares in NY Thread skint 9 3.4K 5 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.4K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread shlok 507 157K 3 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread shlok 507 157K 3 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 0 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 157K 2 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread shlok 507 157K 4 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread shlok 507 157K 4 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Cuprum29 507 157K 3 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 157K 5 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Cuprum29 507 157K 6 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Kyriaco 507 157K 8 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 8
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Mateo335 507 157K 4 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Kyriaco 507 157K 3 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 1 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 157K 3 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 157K 5 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 157K 1 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Mateo335 507 157K 4 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Cuprum29 507 157K 3 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 157K 0 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Cuprum29 507 157K 1 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 157K 6 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 1 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Cuprum29 507 157K 4 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 2 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 1 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Cuprum29 507 157K 4 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 1 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 157K 5 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Kyriaco 507 157K 2 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread MrLearner 507 157K 3 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 1 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 157K 6 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread MrLearner 507 157K 0 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread MrLearner 507 157K 9 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 9
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 3 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Jasper22 507 157K 4 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread shlok 507 157K 4 16/02/25
16/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Jimbob77 507 157K 5 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 157K 11 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 11
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Cuprum29 507 157K 8 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 8
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 157K 4 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Cuprum29 507 157K 0 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Cuprum29 507 157K 0 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 157K 9 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 9
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 157K 3 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Cuprum29 507 157K 0 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread ralphs 507 157K 6 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 157K 3 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 2 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread MrLearner 507 157K 1 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread MrLearner 507 157K 4 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 157K 6 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 2 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Cuprum29 507 157K 1 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 157K 6 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Cuprum29 507 157K 1 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 1 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 157K 9 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 9
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 3 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Cuprum29 507 157K 3 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 0 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 1 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread swaja 507 157K 5 15/02/25
15/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 0 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Cuprum29 507 157K 2 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 2
ASX - By Stock ATH Re: 553,461 shorted shares in NY Thread Kyriaco 9 3.4K 12 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.4K Likes Created with Sketch. 12
ASX - By Stock ATH Re: 553,461 shorted shares in NY Thread Cuprum29 9 3.4K 4 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.4K Likes Created with Sketch. 4
ASX - By Stock ATH Re: 553,461 shorted shares in NY Thread Jasper22 9 3.4K 1 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.4K Likes Created with Sketch. 1
ASX - By Stock ATH Re: 553,461 shorted shares in NY Thread itsagas 9 3.4K 3 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.4K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 157K 2 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Stock price - ATH/ATHE Thread groins 1.8K 585K 6 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 1.8K Views Created with Sketch. 585K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread MrLearner 507 157K 5 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 5
ASX - By Stock ATH Re: 553,461 shorted shares in NY Thread Cuprum29 9 3.4K 3 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.4K Likes Created with Sketch. 3
ASX - By Stock ATH Re: 553,461 shorted shares in NY Thread pierre77 9 3.4K 6 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.4K Likes Created with Sketch. 6
ASX - By Stock ATH Re: 553,461 shorted shares in NY Thread GroRob 9 3.4K 2 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.4K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Stock price - ATH/ATHE Thread itsagas 1.8K 585K 10 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 1.8K Views Created with Sketch. 585K Likes Created with Sketch. 10
ASX - By Stock ATH Re: Stock price - ATH/ATHE Thread rakeshnirzari1 1.8K 585K 14 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 1.8K Views Created with Sketch. 585K Likes Created with Sketch. 14
ASX - By Stock ATH 553,461 shorted shares in NY Thread pivalde 9 3.4K 9 14/02/25
14/02/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.4K Likes Created with Sketch. 9
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 2 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 157K 17 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 17
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Telluride 507 157K 3 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 157K 8 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 8
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Telluride 507 157K 3 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 157K 3 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Telluride 507 157K 3 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Bluesaint 507 157K 3 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Telluride 507 157K 1 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 157K 5 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 1 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Telluride 507 157K 7 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 7
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 157K 4 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 157K 4 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Telluride 507 157K 4 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Kyriaco 507 157K 4 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 157K 4 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Tradeyoursoul 507 157K 1 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Kyriaco 507 157K 7 13/02/25
13/02/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 157K Likes Created with Sketch. 7
refresh Created with Sketch. REFRESH

Featured News

NEWS Bonanza Dittmer Drilling Hits 221g/t Gold in Stage 5 Intersection
right-arrow Created with Sketch.
NEWS FBR Executes Engineering Service Agreement with Samsung Heavy Industries
right-arrow Created with Sketch.
NEWS Agreement for Sale of Mount Mason Project to Gold Valley Yilgarn
right-arrow Created with Sketch.
NEWS High-Grade Gold Hits Extend Major Lodes at Kpali Prospect in Ghana
right-arrow Created with Sketch.
NEWS New Positive Interim Data in Phase 2 Study of SNT-5505 in Myelofibrosis
right-arrow Created with Sketch.
NEWS Ministerial Approval Grants Provisional Authorisation for Battery Anode Material Facility
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $100.4M
Open High Low Value Volume
1.1¢ 1.1¢ 1.1¢ $13.94K 1.316M

Buyers (Bids)

No. Vol. Price($)
33 11062464 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 21951841 11
View Market Depth
Last trade - 12.09pm 17/06/2025 (20 minute delay) ?
Last
1.1¢ 		  Change
0.000 ( 4.55 %)
Open High Low Volume
1.1¢ 1.1¢ 1.1¢ 1344620
Last updated 11.09am 17/06/2025 ?
ATH (ASX) Chart

Top Stories

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Welcome to this week’s HotCopperWire, our market watch podcast!Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through all the week’s biggest news headlines @ and what they mean for Aussie investors.In this Week ...
Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo The current attacks on Iran’s nuclear facilities by Israel mark a new level of escalation in the Middle East. Of course, a radical regime like Iran cannot be allowed to conduct nuclear research. This region has already experienced too much terror.Listen to the HotCopper podcast fo...
Much-shorted Oz Uranium stocks enjoying big week – and big price jumps Australian uranium players like Deep Yellow (ASX:DYL), Boss Energy (ASX:BOE), and Paladin Energy (ASX:PDN) have enjoyed stellar rallies early in Week 25 after top trust Sprott said it would be raising $100 million to buy nuclear fuel.Listen to the HotCopper podcast for in-depth discussions and in...
'Clearly superior': Betr doesn't want to accept PointsBet picking Mixi instead Australian bookmaker Betr (ASX:BBT) insists it has a @clearly superior” proposal to buy up similarly ASX-listed bookie PointsBet (ASX:PBH) when weighed against Mixi and the Japanese giant’s $402 million takeover bid.Listen to the HotCopper podcast for in-dept...
'Encouraging' signs as ASM puts cash-saving options to test at Dubbo drill site Australian Strategic Materials reports "very encouraging" results from cost-effective heap leach metallurgical testing it's running in Dubbo.

Featured News

NEWS Agreement for Sale of Mount Mason Project to Gold Valley Yilgarn
right-arrow Created with Sketch.
NEWS New Positive Interim Data in Phase 2 Study of SNT-5505 in Myelofibrosis
right-arrow Created with Sketch.
NEWS Pathological Complete Response Recorded in ACCENT Trial of Advanced Pancreatic Cancer
right-arrow Created with Sketch.
NEWS FBR Executes Engineering Service Agreement with Samsung Heavy Industries
right-arrow Created with Sketch.
NEWS Bonanza Dittmer Drilling Hits 221g/t Gold in Stage 5 Intersection
right-arrow Created with Sketch.
NEWS Ministerial Approval Grants Provisional Authorisation for Battery Anode Material Facility
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.